Clinical trial · Interventional
Analgesic Efficacy of Erector Spinae Plane Block vs External Oblique Intercostal Plane Block in Subcostal Cancer Surgeries
Analgesic Efficacy of Erector Spinae Plane Block vs External Oblique Intercostal Plane Block in Subcostal Cancer Surgeries: A Randomized Controlled Study
NCT06519708CI-TRIAL-00101339completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to evaluate the impact of ultrasound-guided erector spinae plane block compared to ultrasound-guided external oblique intercostal plane block regarding management of postoperative acute pain in patients undergoing above Umbilical surgical procedure.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Analgesia | — | UNRESOLVED | — |
| Erector Spinae Plane Block | — | UNRESOLVED | — |
| External Oblique Intercostal Plane Block | — | UNRESOLVED | — |
| Subcostal Cancer Surgeries | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Erector Spinae Plane Block | Drug | — | UNRESOLVED |
| External Oblique Intercostal Plane Block | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Erector Spinae Plane Block
- description
- Patients will receive an ultrasound-guided erector spinae plane block with the injection of 30 ml bupivacaine 0.25% after induction of general anesthesia.
- interventionNames
- Drug: Erector Spinae Plane Block
- type
- EXPERIMENTAL
- label
- External Oblique Intercostal Plane Block
- description
- Patients will receive an ultrasound-guided external oblique intercostal plan block Intraoperative with the injection of 30 ml bupivacaine 0.25% after induction of general anesthesia.
- interventionNames
- Drug: External Oblique Intercostal Plane Block
Primary outcomes (1)
- measure
- Total amount of morphine consumption
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Age (18-65) Years. * Both sexes. * Body mass index (BMI): (20-40) kg/m2. * American Society of Anesthesiology (ASA) physical status II, III. * Type of surgery; unilateral subcostal incision in hepatectomy and nephrectomy. Exclusion Criteria: * Patient refusal. * Subcostal incisions that are crossing the midline or midline incision. * Age \<18 years or \>65 years * BMI \<20 kg/m2 and \>40 kg/m2 * Known sensitivity or contraindication to drugs used in the study * Contraindication to regional anesthesia e.g. local infection at the site of introduction, pre-existing peripheral neuropathies, and coagulopathy. * Pregnancy. * Physical status ASA IV * patients on chronic analgesic therapy (daily morphine ≥30 mg or equivalent dose of other opioids or tramadol or any medication for neuropathic pain) * patients with a history of drug abuse * patients with neuropsychiatric diseases; patients with a history of chronic pain syndromes that may enhance sensitivity to pain, for example, fibromyalgia * All patients who are going to have severe intra- or post-operative bleeding or will require postoperative mechanical ventilation are also excluded from the study.
References
Publications (0)
Data not yet available
No reference posted for this study.